Evidence map›Paper›PMID 36090450›Full record

ArticleNature computational science2021

Rapid Assessment of T-Cell Receptor Specificity of the Immune Repertoire.

Xingcheng Lin, Jason T George, Nicholas P Schafer, Kevin Ng Chau, Michael E Birnbaum, Cecilia Clementi, José N Onuchic, Herbert Levine

Abstract read
In one paragraph

Article in Nature computational science, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 34 papers.

0numbers the graph read from it
0cells of the map it votes in
34citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

34 citing papers in PubMed.

  1. Technical review of artificial intelligence in TCR-T therapy.Journal of the National Cancer Center · 2026
    Review
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Limits on inferring T cell specificity from partial information.Proceedings of the National Academy of Sciences of the United States of America · 2024
    Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Xingcheng LinCenter for Theoretical Biological Physics, Rice University, Houston, TX.
Jason T GeorgeCenter for Theoretical Biological Physics, Rice University, Houston, TX.
Nicholas P SchaferCenter for Theoretical Biological Physics, Rice University, Houston, TX.
Kevin Ng ChauDepartment of Physics, Northeastern University, Boston, MA.
Michael E BirnbaumKoch Institute for Integrative Cancer Research, Cambridge, MA.
Cecilia ClementiCenter for Theoretical Biological Physics, Rice University, Houston, TX.
José N OnuchicCenter for Theoretical Biological Physics, Rice University, Houston, TX.
Herbert LevineCenter for Theoretical Biological Physics, Rice University, Houston, TX.

Funding

Co-Evolution of the CD8+ T Cell Repertoire and AML In the Setting of ImmunotherapyF30CA213878 · NCI · RICE UNIVERSITY · PI GEORGE, JASON · 2017 to 2020
$174k
NCI NIH HHS F30 CA213878
6 · The paper itself

Abstract

Accurate assessment of TCR-antigen specificity at the whole immune repertoire level lies at the heart of improved cancer immunotherapy, but predictive models capable of high-throughput assessment of TCR-peptide pairs are lacking. Recent advances in deep sequencing and crystallography have enriched the data available for studying TCR-p-MHC systems. Here, we introduce a pairwise energy model, RACER, for rapid assessment of TCR-peptide affinity at the immune repertoire level. RACER applies supervised machine learning to efficiently and accurately resolve strong TCR-peptide binding pairs from weak ones. The trained parameters further enable a physical interpretation of interacting patterns encoded in each specific TCR-p-MHC system. When applied to simulate thymic selection of an MHC-restricted T-cell repertoire, RACER accurately estimates recognition rates for tumor-associated neoantigens and foreign peptides, thus demonstrating its utility in helping address the large computational challenge of reliably identifying the properties of tumor antigen-specific T-cells at the level of an individual patient's immune repertoire.

Identifiers

PMID36090450
PMCPMC9455901

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.